BAY 56-3722

· Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY 56-3722, covering 2013-07-10 to 2013-07-10. Get the full timeline:

Most recent: Clinical Trial Update: BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer [Phase 2]